Gray Foundation awards $25M for BRCA-related cancer research

From Health Pulse Newsletter in Crain’s New York Business (08/11/2023) The Gray Foundation, a Midtown-based nonprofit that aims to expand BRCA-related cancer research, announced Thursday that it has awarded $25 million for seven research teams to study gene mutations that increase risk of cancer. Women who have a BRCA1 or BRCA2 gene mutation are at […]

The Gray Foundation Announces $25 Million in New Funding for BRCA-Related Cancer Research

The Gray Foundation today announced $25 million in funding for 7 research teams to study new approaches for prevention, early detection, and interception of BRCA-related cancers. The new grants are part of the Foundation’s ongoing Team Science program, which funds innovative BRCA-related collaborative research. For this cycle, the research teams were selected from more than […]

The next big advance in cancer treatment could be a vaccine

After decades of limited success, scientists say research has reached a turning point, with many predicting more vaccines will be out in five years. In Philadelphia, Dr. Susan Domchek, director of the Basser Center at Penn Medicine, is recruiting 28 healthy people with BRCA mutations for a vaccine test. Those mutations increase the risk of […]

Basser Center Holds Fundraiser in Manhattan to Help Cure Cancer

The Basser Center held its “Basser Jean Bash” Tuesday night in Manhattan. People attending were told to wear their most stylish denim because it was an event about your “genes.” This is the 10th year for the fundraiser which helps to raise money to find a cure for BRCA-related cancers.

University Of Pennsylvania Receives $55 Million Gift To Study, Treat Hereditary Cancers

The gift, from Penn alumni Mindy and Jon Gray, will be used to establish the Basser Cancer Interception Institute, at the Basser Center for BRCA, part of Penn’s Abramson Cancer Center. The goal of the Institute is to move up the timeline of cancer treatment, “intercepting” various forms of the disease when abnormal BRCA1/2 cells develop […]